• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Pediatric Infect Dis Soc . Perimyocarditis in Adolescents After Pfizer-BioNTech COVID-19 Vaccine

tetano

Editor, Senior Moderator
J Pediatric Infect Dis Soc


. 2021 Jul 28;piab060.
doi: 10.1093/jpids/piab060. Online ahead of print.
Perimyocarditis in Adolescents After Pfizer-BioNTech COVID-19 Vaccine


Eric Tano[SUP] 1 [/SUP], Stephanie San Martin[SUP] 1 [/SUP], Stephen Girgis[SUP] 1 [/SUP], Yadira Martinez-Fernandez[SUP] 2 [/SUP], Carolina Sanchez Vegas[SUP] 3 [/SUP]



Affiliations

Abstract

On May 10, 2021, the Emergency Use Authorization of the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) was expanded to include adolescents (May 10, 2021. https://www.fda.gov/news-events/pre...fizer-biontech-covid-19-vaccine-emergency-use). We describe clinical characteristics of 8 adolescents who presented over the course of 36 days to Nicklaus Children's Hospital with perimyocarditis within 4 days of receiving a dose of BNT162b2 vaccine.

Keywords: BNT162b2; COVID-19 vaccine; myocarditis; pericarditis.
 
Back
Top Bottom